TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
79 hedge funds and large institutions have $4.56M invested in Tvardi Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-18
Holders Change %
-18.56%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
15
Reduced
24
Closed
34
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
-$26K
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$204K |
| 2 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$107K |
| 3 |
Jane Street
New York
|
+$97.1K |
| 4 |
Goldman Sachs
New York
|
+$87.2K |
| 5 |
Two Sigma Advisers
New York
|
+$52K |
Top Sellers
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$1.41M |
| 2 |
BlackRock
New York
|
-$691K |
| 3 |
AI
Acuitas Investments
Seattle,
Washington
|
-$466K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$355K |
| 5 |
State Street
Boston,
Massachusetts
|
-$212K |
